5th Cytokine-Based Drug Development Summit 2024

Kongressthemen
While leading cytokine therapeutic developers are using next-generation cytokine engineering technologies to tackle enduring efficacy and toxicity challenges to take their molecules through the clinic, the field is also looking to novel targets, novel cytokines and an expanded disease focus.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
URL:
Brochure: https://go.evvnt.com/2140304-3?pid=4832

Speakers: Aaron Meyer, Assistant Professor, UCLA, Audrey Le Floc’h, Associate Director, Regeneron, Bertolt Kreft, Chief Scientific Officer, Bright Peak Therapeutics, and more

https://go.evvnt.com/2140304-2?pid=4832

Herr Hanson Wade